Gilde Healthcare-backed Rad-x buys SMII

The company's founder, Pierre Chevalley, became a shareholder in Rad-x as part of the transaction. The deal was supported by the Gilde Healthcare Services II fund, which remains the group's majority shareholder.

Gilde Healthcare began its buy-and-build strategy in this sector with the acquisition of Geneva-based IRD in January 2017. The platform acquired German rheumatological specialist Acura Kliniken Rhinland-Pfalz in February 2017.

Company
SMII was founded in 2012 by medical entrepreneur Pierre Chevalley and is headquartered in Chaux-de-Fonds. It operates three imaging centres in the Swiss cantons of Neuchâtel, Vaud and Valais.

People
Rad-x – Martin Hardens (CEO).
Swiss Medical Imaging Investment – Pierre Chevalley (CEO).

Advisers
Acquirer – Deloitte Switzerland (financial due diligence); Meyer Avocats (legal); AMS Conseil (tax).
Company – JNC Avocats (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Switzerland
• Build-up
• Gilde Investment Management